Monash University
Browse

Embargoed and Restricted Access

Reason: Under embargo until Jun 2019. After this date a copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library

Targeted delivery of MMP14 inhibitor in a nanodrug construct for stabilization of unstable atherosclerotic plaques to prevent plaque rupture

thesis
posted on 2017-02-21, 00:02 authored by Choy, Mei Yee
The purpose of this research is to design a targeted nanoparticle drug construct with the ability to penetrate the unstable atherosclerotic plaque, stabilize it; as a form of therapy for translation into a prophylaxis against human heart attacks The fully assembled drug construct is a modular prototype of a targeted delivery platform and it comprises 3 components - collagen IV binding heptapeptide, the activatable cell penetrating peptide designed for MMP2 cleavage and the nanosponge loaded with the MMP14 inhibitor drug, Naphthofluoroscein.The research could demonstrate specific entry and lodgment of the fully assembled construct in unstable mouse plaques. Therapy with 2 doses of this construct spread over 4 weeks was found to significantly reduce the MMP14 activity, significantly increase the collagen content of the plaques and mildly reduce the presence of platelets in the treated unstable plaques using the tandem stenosis mouse model of plaque instability.

History

Principal supervisor

Christoph Hagemeyer

Additional supervisor 1

Karlheinz Peter

Year of Award

2016

Department, School or Centre

Central Clinical School

Additional Institution or Organisation

Immunology - Alfred

Campus location

Australia

Course

Doctor of Philosophy

Degree Type

DOCTORATE

Faculty

Faculty of Medicine Nursing and Health Sciences

Usage metrics

    Faculty of Medicine, Nursing and Health Sciences Theses

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC